JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5651
374Water
SCWO
$52.4M
| $66.9K | ﹤0.01% |
4,714
+875
| +23% | +$11.7K |
2023 Q2
2 quarters
|
|
5652
X4 Pharmaceuticals
XFOR
$288M
| $66.9K | ﹤0.01% |
2,660
| – | – |
2022 Q4
4 quarters
|
|
5653
First Trust Eurozone AlphaDEX
FEUZ
$113M
| $66.8K | ﹤0.01% |
1,644
| – | – |
2023 Q1
3 quarters
|
|
5654
CALL
Century Aluminum
CENX
$3.56B
| $66.8K | ﹤0.01% |
+5,500
| New | +$43.2K |
2023 Q4
0 quarters
|
|
5655
Oramed Pharmaceuticals
ORMP
$194M
| $66.4K | ﹤0.01% |
28,766
-17,250
| -37% | -$36.8K |
2021 Q2
10 quarters
|
|
5656
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$188M
| $66.3K | ﹤0.01% |
1,458
-623
| -30% | -$27.2K |
2023 Q3
1 quarter
|
|
|
OPTN
5657
DELISTED
OptiNose
OPTN
| $66.2K | ﹤0.01% |
3,420
-1,353
| -28% | -$24.7K |
2017 Q4
24 quarters
|
|
5658
SKYX Platforms
SKYX
$154M
| $66.1K | ﹤0.01% |
41,324
| – | – |
2023 Q2
2 quarters
|
|
5659
GDS Holdings
GDS
$5.97B
| $66.1K | ﹤0.01% |
7,248
+345
| +5% | +$3.49K |
2017 Q1
27 quarters
|
|
|
MYD
5660
DELISTED
BlackRock MuniYield Fund
MYD
| $66K | ﹤0.01% |
6,125
+5,821
| +1,915% | +$57.1K |
2023 Q1
3 quarters
|
|
|
ASRT
5661
DELISTED
Assertio
ASRT
| $65.9K | ﹤0.01% |
4,104
| – | – |
2015 Q4
32 quarters
|
|
5662
RPAR Risk Parity ETF
RPAR
$547M
| $65.8K | ﹤0.01% |
+3,442
| New | +$61.6K |
2023 Q4
0 quarters
|
|
|
SWKH
5663
DELISTED
SWK Holdings
SWKH
| $65.5K | ﹤0.01% |
4,716
+1,635
| +53% | +$21.3K |
2022 Q2
6 quarters
|
|
5664
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
| $65.2K | ﹤0.01% |
2,930
-1,482
| -34% | -$31.2K |
2023 Q2
2 quarters
|
|
5665
Torrid Holdings
CURV
$226M
| $65K | ﹤0.01% |
11,262
+3,431
| +44% | +$11.7K |
2021 Q3
9 quarters
|
|
5666
Invesco DB Oil Fund
DBO
$295M
| $64.9K | ﹤0.01% |
4,663
-11
| -0.2% | -$175 |
2020 Q4
12 quarters
|
|
|
SILV
5667
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $64.6K | ﹤0.01% |
9,864
+9,087
| +1,169% | +$50.6K |
2023 Q2
2 quarters
|
|
5668
Taysha Gene Therapies
TSHA
$1.54B
| $64.6K | ﹤0.01% |
36,484
+36,347
| +26,531% | +$72.5K |
2020 Q4
12 quarters
|
|
5669
Valhi
VHI
$431M
| $64.6K | ﹤0.01% |
4,251
+2,006
| +89% | +$26.5K |
2016 Q4
28 quarters
|
|
|
EEX
5670
DELISTED
Emerald Holding
EEX
| $63.9K | ﹤0.01% |
10,688
+568
| +6% | +$2.99K |
2023 Q1
3 quarters
|
|
5671
Kodiak Sciences
KOD
$6.19B
| $63.9K | ﹤0.01% |
21,023
-3,286
| -14% | -$7.31K |
2018 Q4
20 quarters
|
|
5672
NLI Holdings
NL
$346M
| $63.8K | ﹤0.01% |
11,370
+5,922
| +109% | +$29.7K |
2016 Q4
28 quarters
|
|
|
PHK
5673
PIMCO High Income Fund
PHK
$775M
| $63.6K | ﹤0.01% |
+12,736
| New | +$57.8K |
2023 Q4
0 quarters
|
|
5674
DNP Select Income Fund
DNP
$3.52B
| $63.5K | ﹤0.01% |
7,480
-16,596
| -69% | -$150K |
2022 Q4
4 quarters
|
|
5675
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.83B
| $63.5K | ﹤0.01% |
2,294
+167
| +8% | +$4.58K |
2023 Q2
2 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.